Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate
- PMID: 475360
- PMCID: PMC352754
- DOI: 10.1128/AAC.15.6.758
Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate
Abstract
Mutants of herpes simplex virus type 1, resistant to phosphonoformate (PFA) and phosphonoacetate (PAA), have been selected in cell culture. The PFA-resistant mutant (HSV-PFA(r)) and the PAA-resistant mutant (HSV-PAA(r)) were also resistant to PAA and PFA, respectively. This cross-resistance indicates that PFA and PAA interact at the same site. The HSV-PFA(r) had a decreased susceptibility to vidarabine, but no difference in sensitivity to idoxuridine (5-iodo-2'-deoxyuridine) was observed when compared to the wild type. The induced deoxyribonucleic acid polymerases isolated from cells infected with HSV-PFA(r) and HSV-PAA(r) were both cross-resistant to inhibition by PFA and PAA. No increased resistance to vidarabine triphosphate could be observed, but the susceptibility to inhibition by pyrophosphate was about two times lower. None of the mutants showed any increased temperature sensitivity
Similar articles
-
Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.Intervirology. 1987;28(2):89-99. doi: 10.1159/000150000. Intervirology. 1987. PMID: 2965115
-
Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.Intervirology. 1978;9(4):193-205. doi: 10.1159/000148937. Intervirology. 1978. PMID: 201588
-
Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.Arch Virol. 1980;65(2):149-56. doi: 10.1007/BF01317326. Arch Virol. 1980. PMID: 6252867
-
The antiherpesvirus action of phosphonoacetate.Pharmacol Ther. 1979;4(1):231-43. doi: 10.1016/0163-7258(79)90021-4. Pharmacol Ther. 1979. PMID: 88744 Review. No abstract available.
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
Cited by
-
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.J Virol. 1985 Feb;53(2):477-88. doi: 10.1128/JVI.53.2.477-488.1985. J Virol. 1985. PMID: 2982032 Free PMC article.
-
Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.Antimicrob Agents Chemother. 1981 May;19(5):927-9. doi: 10.1128/AAC.19.5.927. Antimicrob Agents Chemother. 1981. PMID: 6271053 Free PMC article.
-
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.Antimicrob Agents Chemother. 1982 Dec;22(6):1026-30. doi: 10.1128/AAC.22.6.1026. Antimicrob Agents Chemother. 1982. PMID: 6297382 Free PMC article.
-
Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.Arch Virol. 1982;73(2):135-43. doi: 10.1007/BF01314722. Arch Virol. 1982. PMID: 6184033
-
Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.Arch Virol. 1981;68(3-4):203-9. doi: 10.1007/BF01314573. Arch Virol. 1981. PMID: 6268019
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources